At three years, 87% of men receiving combination treatment remained free of detectable cancer spread, compared with 78% in the surgery-only group. The combination also reduced the risk of needing additional treatment, such as radiation therapy, by 71%.
Tips for Managing RLS With C3G When RLS symptoms are mild or occur occasionally, a few tweaks to your daily routine and bedtime habits may […]
Shutting down immunization services in the COVID-19 pandemic risks triggering a resurgence of diseases that can be prevented with safe and effective vaccines, warns WHO […]
Follow us Add us as a preferred source on Google Newsletter Subscribe to our newsletter Artificial intelligence (AI) tools like chatbots are becoming part of […]